Hypomethylating agents plus venetoclax for high-risk MDS and CMML as bridge therapy to transplant: a GESMD study. - Zugasti, Ines; Lopez-Guerra, Monica; Castaño-Díez, Sandra; Esteban, Daniel; Avendaño, Alejandro; Pomares, Helena; Perez, Ana; García-Ávila, Sara; Conejo, Irene Padilla; de la Fuente Montes, Cristina; Martínez-Roca, Alexandra; Merchán, Beatriz; et al. (Experimental Hematology & Oncology, 2025)